IDENTI Medical is addressing one of the most overlooked challenges in healthcare: the lack of accurate, real-time data inside the operating room.
In this interview, CEO Shlomo Matityaho explains how hospitals lose billions of dollars due to missing surgical data, and how IDENTI’s operating room computer vision technology captures exactly what happens during procedures. By combining real-time data capture with AI and machine learning, hospitals can improve billing accuracy, optimize operations, and enhance clinical outcomes with accurate operating room data analytics.
With deployments across Israel and growing traction in the U.S., including leading hospitals like Mayo Clinic, IDENTI Medical is redefining how hospitals use data to drive efficiency and financial performance.
Host: Alright, now we’d like to welcome Shlomo Matityaho, CEO and Founder of IDENTI Medical. Good afternoon.
Shlomo: Good afternoon, nice to be here.
Host: Thank you for joining us. To start, could you tell us a bit about your company?
Shlomo: IDENTI Medical operates in the healthcare sector. We develop, manufacture, and provide solutions for hospitals in Israel and globally, focusing on improving operational processes and enhancing clinical outcomes.
Host: And currently you’re active in Israel, with plans to expand further internationally?
Shlomo: Yes. We’re active across all hospitals in Israel. We also operate in France and Greece, and in recent years, we’ve been developing the U.S. market. We’ve already had promising initial engagements with hospitals such as the Mayo Clinic and others in the United States.
Host: Can you explain the solutions you offer and how they help hospitals save significant costs?
Shlomo: We identified a major gap between hospitals’ clinical capabilities and their operational, logistical, and even financial capabilities. This gap largely stems from a lack of digital data within hospital systems. IDENTI developed a suite of solutions, the core of which is an imaging system installed in operating rooms. This system documents what is used during surgery through visual capture. This capability enables hospitals to know exactly which items were used during procedures. That impacts multiple areas:
- Clinical: What implant was used for a patient
- Financial: How much can be billed to insurance companies
- Operational: Inventory and process optimization
Our technology allows hospitals to significantly improve across all these dimensions.
At the beginning, we essentially created a platform connecting medical device manufacturers with hospitals. This alone saved hospitals millions of dollars in the Israeli market. From there, we expanded into a broader suite of solutions, first in Israel and then internationally.
Host: What kind of feedback are you receiving from hospitals in the U.S.?
Shlomo: The feedback is very strong. U.S. hospitals face the same challenges as Israeli hospitals.
Just yesterday, I spoke with Boston Medical Center. One of the things they told me is that anyone who sees this imaging technology immediately recognizes it as a breakthrough—and wants to implement it as quickly as possible.
Today, U.S. hospitals lose billions of dollars due to the lack of this type of data—specifically, the inability to fully understand what happens in the operating room and what items are used.
Their ability to receive reimbursements from insurance companies is significantly affected by missing data. IDENTI provides that data with full accuracy, along with additional insights collected by AI and machine learning technologies integrated into hospital systems.
Host: You also went public about five years ago. Tell us about that.
Shlomo: Yes, that was an interesting move. Until that point, the company was fully bootstrapped—everything was funded from internal resources.
The decision to go public came from recognizing our strong traction in Israel and believing there was no reason we couldn’t replicate that success in the U.S. market.
The challenge for a company like ours in the public market is that investors expect rapid results. However, in healthcare technology—especially in a relatively conservative industry—adoption takes time.
Host: So the stock is dual listed?
Shlomo: It’s only in Tel Aviv.
Host: Over the past year, the stock has declined by around 40%. How do you explain that?
Shlomo: As I mentioned, the market expects fast updates and visible progress.
But looking forward, after about three years of building the U.S. market, we’ve reached a point where we now have real orders from hospitals like the Mayo Clinic, OrthoVirginia, and others.
We’re entering 2026 with meaningful orders in hand and a strong pipeline for the year. We believe we’ve reached an inflection point where growth will accelerate—impacting both our business results and, we believe, the stock price.
Host: We wish the business and the stock market price a lot of luck. Shlomo Matityaho, CEO and Founder of IDENTI Medical—thank you very much.
Shlomo: Thank you.
